efavirenz

CD4 molecule ; Homo sapiens







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34280356 Efficacy of vitamin D supplementation among persons living with HIV/AIDS in São Paulo city, Brazil. 2021 May-Jun 1
2 32702281 Impact of antiretroviral regimen on viral suppression among pregnant women living with HIV in Brazil. 2020 Aug 1
3 33116922 Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia. 2020 1
4 31409277 Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe. 2019 Aug 13 1
5 29308748 Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran. 2018 3
6 29534103 Prevalence and correlates of persistent intracellular HIV transcription in individuals on efavirenz versus atazanavir-based regimens: A prospective cohort study. 2018 2
7 29875890 Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine versus Zidovudine-Lamivudine-Efavirenz Antiretroviral Treatment (ART) Among HIV-1 Infected Children: Asella Teaching and Referral Hospital, South-East Ethiopia. 2018 1
8 28143541 Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort study. 2017 Feb 1 1
9 26906233 Acute myelitis by human herpes virus 7 in an HIV-infected patient. 2016 Apr 1
10 26945366 Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. 2016 Mar 1
11 27646953 Immune reconstitution inflammatory syndrome associated with dermatophytoses in two HIV-1 positive patients in rural Tanzania: a case report. 2016 Sep 20 1
12 25777186 Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: a meta-analysis. 2015 Jan-Feb 1
13 30222398 Treatment Outcomes of Nevirapine- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Antiretroviral-Naive Adult Patients in Ethiopia: A Cohort Study. 2015 May 1
14 25433665 Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: a meta-analysis. 2014 Nov-Dec 1
15 23372824 Effectiveness of efavirenz-based regimens in young HIV-infected children treated for tuberculosis: a treatment option for resource-limited settings. 2013 1
16 22309114 Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. 2012 Sep 1
17 20090545 Prospective, randomized, open label trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ treatment-naive subjects with CD4+<200 cell/mm3 in Mexico. 2010 Apr 1
18 20404738 Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses. 2010 Sep 1
19 18097230 Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection. 2008 Jan 11 2
20 18419537 Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts. 2008 Apr 1 1
21 17653450 Comparison of the effectiveness of initial combined antiretroviral therapy with nelfinavir or efavirenz at a university-based outpatient service in Brazil. 2007 Jul 1
22 17667341 Response to efavirenz-containing regimens in previously antiretroviral-naive HIV-positive patients: the role of gender. 2007 Sep 1 1
23 17713424 Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease. 2007 Sep 1
24 17057609 Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysis. 2006 Dec 15 1
25 17100373 Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3. 2006 Sep 1
26 17334006 Nevirapine versus efavirenz based antiretroviral treatment in naive Indian patients: comparison of effectiveness in clinical cohort. 2006 Dec 1
27 16452064 Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine. 2005 Nov-Dec 1
28 9878993 Efavirenz. 1998 Dec 1